Your session is about to expire
← Back to Search
Behavioral Intervention
Exercise Intervention for Age-Related Macular Degeneration
N/A
Recruiting
Led By Joe R. Nocera, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from best corrected visual acuity at 6 months
Awards & highlights
Study Summary
This trial aims to use exercise to help Veterans with AMD improve physical, cognitive, and visual outcomes. There are no cures or treatments, so this could benefit the aging Veteran population.
Who is the study for?
This trial is for US Veterans aged 65-89 with intermediate stage Age-Related Macular Degeneration (AMD) in at least one eye. They must be cognitively intact, free from major diseases affecting exercise ability or brain function, not have severe psychiatric disorders or substance abuse issues, and must have stable internet access.Check my eligibility
What is being tested?
The study tests the effects of a 6-month online group spin cycling program on physical, cognitive, and visual outcomes in Veterans with AMD. It aims to see if this aerobic exercise can improve vision loss caused by AMD as well as enhance overall quality of life.See study design
What are the potential side effects?
While specific side effects are not listed for spinning exercises, participants may experience general exercise-related discomforts such as muscle soreness or fatigue. The risk of injury could also increase due to balance issues related to age and potential vision impairment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline contrast sensitivity at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline contrast sensitivity at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Dark adaptometry
contrast sensitivity
Secondary outcome measures
Best Corrected Visual Acuity
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SPINExperimental Treatment1 Intervention
Exercise 3 times a week on a stationary ergometer @ 50-80% of maximal heart rate reserve for 20 minutes to 45 minutes per session
Group II: Non-aerobic, stretching/balance intervention ControlActive Control1 Intervention
For this arm of the intervention, randomized participants followed the same guidelines as the SPIN group but did not partake in aerobic exercise. To equalize contact/monitoring of the groups this group met for the same total duration time as the SPIN group; however, instead of aerobic exercise, progressive whole body stretching and toning exercises
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,214 Total Patients Enrolled
Joe R. Nocera, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
4 Previous Clinical Trials
298 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of heart disease or heart attack.I am a veteran aged 65-89 with intermediate AMD in one eye and can participate in assessments.I don't have any diseases that affect my thinking, heart, liver, kidney, or brain.I speak English as my first language and have finished high school.
Research Study Groups:
This trial has the following groups:- Group 1: SPIN
- Group 2: Non-aerobic, stretching/balance intervention Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical trial accept individuals aged 35 or older?
"Elderly individuals between the ages of 65 and 89 can participate in this clinical trial."
Answered by AI
Is enrollment available for this experiment at the present time?
"As per clinicaltrials.gov, this research project no longer requires new participants; the original post was published on October 1st 2023 and the page was last updated on June 26th 2023. However, there are currently 167 other medical trials that remain open for enrolment."
Answered by AI
Who is most likely to benefit from participating in this research?
"This clinical trial demands that applicants are over 65 and have age-related macular degeneration; the maximum number of patients being accepted is 70."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger